Skip to content

Treatment of irritable bowel syndrome by homoeopathy

Role of individualized homoeopathic treatment in irritable bowel syndrome- An open label observational study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/11/029152
Enrollment
50
Registered
2020-11-17
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K58- Irritable bowel syndrome

Interventions

Intervention1: Individualized homoeopathic medicine in centesimal or 50 millesimal potencies: In centesimal potencies, Dose-Each dose will consist of 4-6 cane sugar globules of no.10 moistened with th

Sponsors

The Calcutta Homoeopathic Medical College and Hospital Govt of West Bengal
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients fulfilling Rome IV criteria for functional IBS 2.Patient having capability and willingness to follow the protocol requirement as evidenced by written, informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients who will decline informed consent or are unwilling to participate in the study 2. Diagnosed cases of unstable psychiatric or uncontrolled or life threatening systemic illness or any organ failure 3. Presence of significant alcoholism or drug abuse 4. Pregnant and lactating women 5. Patient undergoing homoeopathic treatment for any chronic disease within last 4 weeks

Design outcomes

Primary

MeasureTime frame
IBS Symptom severity scale (IBS SSS)Timepoint: At baseline, every month, up to 3 months

Secondary

MeasureTime frame
Measure Yourself Medical Outcome Profile (MYMOP2)Timepoint: At baseline, every month, up to 3 months

Countries

India

Contacts

Public ContactDR HIMANGSU HAIT

The Calcutta Homoeopathic Medical College And Hospital

haitdrhimangsu@gmail.com9433565680

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026